PATENT CLAIM ANALYSIS

Application Number: 15867254
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "654000"]

Abstract:
The invention relates to an aqueous pharmaceutical composition for parenteral administration comprising Tapentadol or a physiologically acceptable salt thereof, wherein the concentration of Tapentadol is within the range of from 0.10 to 8.00 mg/mL, based on the weight of Tapentadol free base and based on the total volume of the composition; and wherein the pH value of the composition is buffered and within the range of from 4.0 to 6.0. The invention also relates to a container comprising the pharmaceutical composition and a process for the preparation thereof. The invention also relates to a kit comprising the contained according to the invention in a packaging. The pharmaceutical composition according to the invention is particularly useful for treating pain, especially acute pain, preferably in pediatric patients.

Claim (Index 76):
The composition according to  claim 62 , which has a titration acidity of not more than 1.8 mmol/L.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 2.09375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13410837', '15257972', '13891306', '15107503', '13387959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7197227854293711
- 35 USC 102 Novelty (BERT): 0.5065492620137501
- Combined Prediction Score: 0.698405433087809
- Mean Citation Score: 151.033522
- Max Citation Score: 178.61777
- Similarity Product: 99.6995847399962

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test